Biotech - Press Releases

Date	Title	Company
15-Dec-2021	Depixus Raises EUR 30.6M (USD 35.4M) in Series A Financing	Depixus
15-Dec-2021	Abzena Promotes Troy Wright to Senior Vice President and Global Head of Quality	Abzena
15-Dec-2021	Contipharma launches saliva-based Omicron detecting PCR test in Africa	Andrew Lloyd Associates
14-Dec-2021	AgeX Therapeutics to Collaborate With University of California, Irvine, on Research Program for Exosome-Based Therapies for Certain Brain Disorders	AgeX Therapeutics
14-Dec-2021	Limbach Group adopts QuantaMatrix dRAST™ in routine clinical use	Andrew Lloyd Associates
14-Dec-2021	Novavax Files for Emergency Use of COVID-19 Vaccine in the United Arab Emirates	Novavax
14-Dec-2021	Moderna and Australia Announce Collaboration to Bring MRNA Manufacturing to Australia	Moderna
14-Dec-2021	Vaccitech acquires Avidea Technologies to expand product pipeline and strengthen scientific leadership in immunotherapies and vaccines	Vaccitech plc
14-Dec-2021	Vésale bioscience named most innovative start-up in life sciences in europe at tenth edition of biofit	Andrew Lloyd Associates
14-Dec-2021	Ferrer and cnic unveil results of first real-world study of cnic-polypill showing decreased risk of major adverse cardiovascular events when compared to monocomponents administered separately	Andrew Lloyd Associates
14-Dec-2021	Advent france biotechnology becomes AdBio partners	Andrew Lloyd Associates
14-Dec-2021	HYPNOVR raises €4.5 million to accelerate the roll out of its digital therapy treating pain and anxiety	Andrew Lloyd Associates
13-Dec-2021	Endogena Completes Series A with Total Funding of $29 million to Progress Treatments for Degenerative Diseases of the Eye	Endogena
13-Dec-2021	Rejuveron Increases to Near-majority Stake in Endogena Through Funding $20m to Progress Treatments for Degenerative Diseases of the Eye Holding increased to near-majority in endogenous regenerative medicine pioneer	Rejuveron
10-Dec-2021	ATMPS and Assurea LLC launch strategic collaboration for advanced therapy supply chain	ATMPS Ltd
10-Dec-2021	Vésale Bioscience named most innovative start-up in life sciences in Europe at tenth edition of BioFIT	Andrew Lloyd Associates
09-Dec-2021	TB Diagnostics company PBD Biotech appoints new CEO	PBD Biotech
09-Dec-2021	OKYO Pharma Limited ("OKYO" or the "Company") to File IND in Q3 2022 for OK-101 to treat Dry Eye Disease ("DED") and to go directly to a Phase 2 Human Clinical Efficacy Trial in DED Patients with a planned start date in Q4 2022 on an accelerated basis	OKYO Pharma Limited
09-Dec-2021	ISA Pharmaceuticals to present key learnings for cancer vaccine development at the ESMO Immuno-Oncology Congress	ISA Pharmaceuticals
09-Dec-2021	Ferrer and CNIC unveil results of first real-world study of CNIC-Polypill showing decreased risk of Major Adverse Cardiovascular Events when compared to monocomponents administered separately	Andrew Lloyd Associates